You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sarcoglycan

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-9003)

Enrolling by invitation
  • Limb Girdle Muscular Dystrophy
  • SRP-9003
  • Columbus, Ohio
    Nationwide Children's Hospital
May 17, 2023

Limb-Girdle Muscular Dystrophy, Type 2E Trial in Columbus (SRP-9003)

Active, not recruiting
  • Limb-Girdle Muscular Dystrophy, Type 2E
  • SRP-9003
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 28, 2022

LGMD2C Trial (ATA-200)

Not yet recruiting
  • LGMD2C
  • ATA-200
  • (no location specified)
Aug 1, 2023

LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, = 4 Years of Age, Who Are

Recruiting
  • Limb-girdle Muscular Dystrophy
    • Phoenix, Arizona
    • +14 more
    Aug 23, 2022

    Long-Term Development of Muscular Dystrophy Outcome Assessments

    Not yet recruiting
    • LGMD1A
    • +33 more
      • Richmond, Virginia
        Virginia Commonwealth University
      Aug 3, 2023

      Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy

      Recruiting
      • Limb Girdle Muscular Dystrophy
      • Muscular Dystrophies
        • Irvine, California
        • +10 more
        Sep 13, 2021

        Duchenne Muscular Dystrophy Trial in Columbus (rAAVrh74.MCK.GALGT2)

        Active, not recruiting
        Has Results
        • Duchenne Muscular Dystrophy
        • rAAVrh74.MCK.GALGT2
        • Columbus, Ohio
          Nationwide Children's Hospital
        Jul 26, 2022

        Pilot Study of Cardiac MR in Patients With Muscular Dystrophy

        Recruiting
        • Muscular Dystrophies
        • +3 more
          • Washington, District of Columbia
            Children's National Health System
          Mar 1, 2022

          Genetics of Cardiovascular and Neuromuscular Disease

          Recruiting
          • Cardiomyopathy
          • +2 more
          • Blood draw (genetic testing)
          • Chicago, Illinois
            University of Chicago
          Aug 23, 2016

          Muscular Dystrophies Trial in Columbus (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort, Genetic:

          Completed
          • Muscular Dystrophies
          • rAAV1.tMCK.human-alpha-sarcoglycan- First cohort
          • Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort
          • Columbus, Ohio
            The Research Institute at Nationwide Children's Hospital
          Feb 4, 2013

          Limb Girdle Muscular Dystrophy Type 2C, Gamma-sarcoglycanopathy Trial in Paris (AAV1-gamma-sarcoglycan vector injection)

          Completed
          • Limb Girdle Muscular Dystrophy Type 2C
          • Gamma-sarcoglycanopathy
          • AAV1-gamma-sarcoglycan vector injection
          • Paris, France
            Hôpital Pitié-Salpêtrière
          Apr 28, 2011